An international team of tropical disease control experts has urged the global health and development community, and particularly the G8 leaders, to establish a new financing mechanism to combat the neglected tropical diseases (NTDs) of poverty.
A "Global Fund to Fight Neglected Tropical Diseases," say Professor Hotez (Sabin Vaccine Institute and George Washington University, Washington, DC, USA) and colleagues, would "satisfy an urgent need to support NTD control and elimination." Their argument is published in the March 26th issue of the open-access journal PLoS Neglected Tropical Diseases.
The NTDs, such as intestinal worms, schistosomiasis, elephantiasis, and river blindness, represent the most common infections of the world's poorest—the bottom billion. They are a major reason, say the authors, why the world's poorest people cannot escape a vicious, downward spiral of poverty.
Fortunately, they say, "we are now in a unique position to control or eliminate some of the highest burden NTDs through integrated use of donated drugs." The mass administration of such drugs just once a year has been the cornerstone of global projects aimed at tackling several of the NTDs, and the launch of a dedicated fund to scale up these activities would be "one of the most cost-effective and urgently needed approaches for sustainable poverty reduction."
A blueprint for such a funding mechanism already exists: the Global Fund to Fight AIDS, Tuberculosis and Malaria, established in 2002, has attracted $4.7 billion in financing for these three diseases. Professor Hotez and colleagues argue that the mandate of this fund could easily be expanded to include the NTDs.
Thus a new fund for NTDs could be established that uses a similar mechanism to that of the Global Fund to Fight AIDS, Tuberculosis and Malaria. Countries burdened by NTDs would apply to the new fund for financing for NTD control efforts, and an expert board (supported by the expertise of the World Health Organization) could vet the applications.